Skip to content
My WebMD Sign In, Sign Up

Cancer Health Center

Font Size

Adrenocortical Carcinoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Cellular Classification of Adrenocortical Carcinoma

Adrenocortical carcinoma can be classified into functioning and nonfunctioning tumors by clinical and biochemical assessment. Approximately 60% of adrenocortical carcinomas produce hormones.[1] The associated clinical syndromes include the following:

Biochemical assessment aims to detect increased levels of cortisol (24-hour urine, 1 mg dexamethasone suppression test, serum adrenocorticotropic hormone and cortisol), androgens (dehydroepiandrosterone sulfate, testosterone), estrogens (estradiol) and mineralocorticoids (renin, aldosterone).

Recommended Related to Cancer

To Learn More About Transitional Cell Cancer of the Renal Pelvis and Ureter

For more information from the National Cancer Institute about transitional cell cancer of the renal pelvis and ureter, see the following: Transitional Cell Cancer (Kidney/Ureter) Home Page Smoking Home Page (Includes help with quitting) For general cancer information and other resources from the National Cancer Institute, see the following: What You Need to Know About™ Cancer Understanding Cancer Series: Cancer Cancer Staging Chemotherapy and You: Support for People With...

Read the To Learn More About Transitional Cell Cancer of the Renal Pelvis and Ureter article > >

Pathology can differentiate high-grade and low-grade tumors according to the mitotic activity of the tumor. The differentiation of benign and malignant adrenocortical tumors can be achieved by determination of the Weiss score, which scores several histopathological criteria, including the following:[2]

  • Nuclear grade.
  • Number of mitoses.
  • Presence of atypical mitosis.
  • Percentage of clear cells.
  • Diffuse architecture.
  • Necrosis.
  • Venous invasion.
  • Sinusoidal invasion.
  • Capsular invasion.

References:

  1. Allolio B, Fassnacht M: Clinical presentation and initial diagnosis. In: Hammer GD, Else T, eds.: Adrenocortical Carcinoma: Basic Science and Clinical Concepts. New York, Springer, 2010, pp 31-47.
  2. Weiss LM, Medeiros LJ, Vickery AL Jr: Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13 (3): 202-6, 1989.
1

WebMD Public Information from the National Cancer Institute

Last Updated: February 25, 2014
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:

Today on WebMD

Building a Support System
Blog
cancer fighting foods
SLIDESHOW
 
precancerous lesions slideshow
SLIDESHOW
quit smoking tips
SLIDESHOW
 
Jennifer Goodman Linn self-portrait
Blog
what is your cancer risk
HEALTH CHECK
 
colorectal cancer treatment advances
Video
breast cancer overview slideshow
SLIDESHOW
 
prostate cancer overview
SLIDESHOW
lung cancer overview slideshow
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
Actor Michael Douglas
Article